Antimicrobial Use and Serious Infections Among Patients With Psoriatic Arthritis After Initiating Tumor Necrosis Factor Inhibitors: A Nationwide Matched Cohort Study
In Table 1, the units for the last row were labelled incorrectly. The value in the parentheses represents the number of individuals affected by serious infections, as some individuals had > 1 event of a serious infection. The revised variable is “No. of serious infections (n individuals).” We apologize for this error. This correction applies to the August 1 2025 First Release and print issue. The online version has been corrected. J Rheumatol 2025; doi: 10.3899/jrheum.2025-0029
Authors
- Sigurður Y. Kristinsson (ORCID: https://orcid.org/0000-0002-4964-7476)
- Telma Thrastardottir (ORCID: https://orcid.org/0000-0002-5997-3398)
- Arna Hauksdóttir (ORCID: https://orcid.org/0000-0002-4253-1059)
- Alexis Ogdie (ORCID: https://orcid.org/0000-0002-4639-0775)
- Aron Hjalti Björnsson (ORCID: https://orcid.org/0000-0002-2595-7015)
- Björn Guðbjörnsson (ORCID: https://orcid.org/0000-0003-4631-6505)
- Þorvarður Jón Löve (ORCID: https://orcid.org/0000-0002-2680-6120)
Institutions
- Reykjavík University (IS)
- University of Iceland (IS)
- National University Hospital of Iceland (IS)
- University of Pennsylvania (US)
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2025-12-03
- DOI
- https://doi.org/10.3899/jrheum.2025-0029.c1
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00